| Bioactivity | BMS-764459 is a CRF1 antagonist. BMS-764459 can be used for the research of neurological disorders such as depression and anxiety. BMS-764459 is also an atypical CYP1A1 inducer[1][2]. |
| Target | CRF1, CYP1A1 |
| Name | BMS-764459 |
| CAS | 1188407-45-5 |
| Formula | C19H21F2N5O3 |
| Molar Mass | 405.40 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. David K. Leahy, et al. Development of an Efficient Synthesis of Two CRF Antagonists for the Treatment of Neurological Disorders. Org. Process Res. Dev. 2010, 14, 5, 1221-1228. [2]. Simic D, et al. MicroRNA changes associated with atypical CYP1A1 inducer BMS-764459. Toxicology. 2013 Sep 15;311(3):169-77. |
BMS-764459
CAS: 1188407-45-5 F: C19H21F2N5O3 W: 405.40
BMS-764459 is a CRF1 antagonist. BMS-764459 can be used for the research of neurological disorders such as depression an
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.